Correlation Between Agilent Technologies and Amylyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Agilent Technologies and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Amylyx Pharmaceuticals.
Diversification Opportunities for Agilent Technologies and Amylyx Pharmaceuticals
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Agilent and Amylyx is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Amylyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Agilent Technologies and Amylyx Pharmaceuticals
Taking into account the 90-day investment horizon Agilent Technologies is expected to under-perform the Amylyx Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Agilent Technologies is 2.08 times less risky than Amylyx Pharmaceuticals. The stock trades about -0.36 of its potential returns per unit of risk. The Amylyx Pharmaceuticals is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 373.00 in Amylyx Pharmaceuticals on January 10, 2025 and sell it today you would lose (24.00) from holding Amylyx Pharmaceuticals or give up 6.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agilent Technologies vs. Amylyx Pharmaceuticals
Performance |
| Timeline |
| Agilent Technologies |
| Amylyx Pharmaceuticals |
Agilent Technologies and Amylyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and Amylyx Pharmaceuticals
The main advantage of trading using opposite Agilent Technologies and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.| Agilent Technologies vs. Danaher | Agilent Technologies vs. Illumina | Agilent Technologies vs. IDEXX Laboratories | Agilent Technologies vs. Waters |
| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |